Molecular Partners Ag (MOLN) Return on Assets ROA from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, Average High and Low, Fundamental Ratios from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Molecular Partners Ag  (NASDAQ: MOLN)


Molecular Partners Ag's ROA from the fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Molecular Partners Ag's ROA in the fourth quarter of 2025?
Molecular Partners Ag recorded a cumulative net loss of $-99 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on assets (ROA) of -81.04%.

However, within the Healthcare sector 693 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2025 from to 4703.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Total Assets Change -22.07 % -26.4 % -37.75 % -26.4 % -21.8 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -99 -86 -86 -78 -78
Return On Assets (TTM) -81.04 % -65.51 % -60.22 % -49.21 % -45.88 %
MOLN's Total Ranking # 4703 # # # # 4544
Total Assets (TTM) in million 129 129 103 129 165
Seq. Total Assets Change 0 % 24.59 % -19.74 % -22.07 % -5.56 %
Seq. Net Income Change - - - - -

MOLN's 5 Years Annual ROA >> Back to MOLN Management Effectiveness >> Compare MOLN ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 103
Sector # 694
Overall # 4663

Return On Assets Statistics
High Average Low
44.94 %
-20.2 %
-60.38 %
(Dec 31 2022)   (Dec 31 2025)





Financial Statements
Molecular Partners Ag's Assets $ 129 million MOLN's Balance sheet
Molecular Partners Ag's Income $ -74 million Quarterly MOLN's Income Statement
MOLN's Income by Division See MOLN's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change -35.59 % -20.08 % -24.37 % 38.65 % -
Total Assets in million 102 159 198 262 189
Y / Y Net Income Change - - - - -
Net Income in million -62 -54 -62 118 -64
Annual Return On Assets -60.38 % -34.09 % -31.25 % 44.94 % -33.72 %

MOLN's 5 Years Annual ROA >> Back to MOLN Management Effectiveness >> Compare MOLN ROA to its Competitors



More Return On Assets Ratios
MOLN's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MOLN's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MOLN's Competitors
Subscribers only: Roa for Molecular Partners Ag's Suppliers
Subscribers only: Return On Assets for MOLN's Customers

You may also want to know
MOLN's Roi MOLN's Inventory Turnover Ratio MOLN's Growth Rates MOLN's Dividend Comparisons
MOLN's Profitability Ratios MOLN's Asset Turnover Ratio MOLN's Dividend Growth
MOLN's Roe MOLN's Valuation Ratios MOLN's Financial Strength Ratios MOLN's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2025, within Healthcare Sector ROA

Date modified: 2026-09-09T12:37:57+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.